This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Feb;13(2):115-6.

doi: 10.1016/S1470-2045(11)70394-1. Epub 2011 Dec 20.

VEGF Trap for the treatment of malignant ascites

Gerhild Becker¹, Hubert E Blum

Affiliations

PMID: 22192728
DOI: 10.1016/S1470-2045(11)70394-1

Comment

VEGF Trap for the treatment of malignant ascites

Gerhild Becker et al. Lancet Oncol. 2012 Feb.

. 2012 Feb;13(2):115-6.

doi: 10.1016/S1470-2045(11)70394-1. Epub 2011 Dec 20.

Authors

Gerhild Becker¹, Hubert E Blum

Affiliation

¹ Department of Palliative Care, University Hospital Freiburg, D-79106 Freiburg, Germany. gerhild.becker@uniklinik-freiburg.de

PMID: 22192728
DOI: 10.1016/S1470-2045(11)70394-1

No abstract available

PubMed Disclaimer

Comment on

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study.
Gotlieb WH, Amant F, Advani S, Goswami C, Hirte H, Provencher D, Somani N, Yamada SD, Tamby JF, Vergote I. Gotlieb WH, et al. Lancet Oncol. 2012 Feb;13(2):154-62. doi: 10.1016/S1470-2045(11)70338-2. Epub 2011 Dec 20. Lancet Oncol. 2012. PMID: 22192729 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information